This symposium aims at complementing the upcoming Baveno VIII Consensus Conference by focusing on refining clinical trial design for portal hypertension and advanced chronic liver disease. The primary objective is to provide attendees with a strong methodological foundation for designing clinical trials that would be best suited to generate evidence that will inform and shape the practice recommendations developed during the Baveno VIII Consensus Conference.

WHO SHOULD ATTEND?

The event welcomes a diverse audience, including clinicians, researchers, and professionals interested in the latest developments in advanced chronic liver disease and portal hypertension.

The symposium will feature insights from renowned experts, addressing:

• Current challenges in designing clinical trials for portal hypertension and advanced chronic liver disease

• Methodologies to evaluate treatment effects and manage heterogeneity

• The role of surrogate outcomes in clinical trials

• Applications of Bayesian inference in clinical trials and observational studies

Registrations are accepted until 28^th February 2025 for both Baveno members and non-members.
Non-members and non-sponsoring industry delegates are invited to make sure that the registration fee is paid by 28^th February 2025 on the Baveno bank account.

FREE PARTICIPATION

Available to approved Baveno members and a limited number of sponsoring industry delegates.

REGISTRATION FEES

Applicable to non-members and non-sponsoring industry delegates, with payment required prior to the event.

A link to the Zoom webinar session will be sent to those who have registered by the deadline (28th February 2025).

Please check your email and spam folder.

Questions/Answers during the webinar will be moderated by the Chairs through the chat.

GOLD SPONSOR

BRONZE SPONSOR